FDA approves Lupin depression, anxiety drug

BY Alaric DeArment

BALTIMORE — The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.

The Indian drug maker announced the approval of escitalopram tablets in the 5-mg, 10-mg and 20-mg strengths, used for acute and maintenance treatment of major depressive disorder in adults and adolescents and for acute treatment of general anxiety disorder in adults.

The drug is a generic version of Forest Labs’ Lexapro, which had sales of about $2.7 billion during the 12-month period that ended in June 2012, according to IMS Health.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 


Leave a Reply

Jan-09-2013 02:22 am

Food and Drug Administration an organization which worked from years to protect and promoting public health through various policies and reforms acts. So before passing or approves any drugs, medicine and diet pills FDA first give the clearance then afterwards these cases are approved. Escitalopram tablets in the 5-mg, 10-mg and 20-mg mostly known as anxiety drugs is now approved by FDA for public use.



What area is your company focused most on in 2019?
  • Add your answer